CIDARA THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-05-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-04-24; Total offering amount $240,000,000.
- 2019-09-13: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-09-03; Total offering amount $9,008,173.
- 2017-10-31: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-10-24; Total offering amount $20,160,000.
- 2015-02-17: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-02-10; Total offering amount $42,019,999.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2024-05-06 | Rule 506(b) | Equity | 2024-04-24 | $240,000,000 | $240,000,000 | $0 | 7 |
| 2019-09-13 | Rule 506(b) | Equity | 2019-09-03 | $9,008,173 | $9,008,173 | $0 | 1 |
| 2017-10-31 | Rule 506(b) | Equity | 2017-10-24 | $20,160,000 | $20,160,000 | $0 | 16 |
| 2015-02-17 | Rule 506(b) | Equity | 2015-02-10 | $42,019,999 | $42,019,999 | $0 | 19 |
| 2014-06-17 | Rule 506(b) | Equity | 2014-05-30 | $42,743,763 | $30,332,199 | $12,411,564 | 8 |
| 2014-06-17 | Rule 506(b) | Equity | 2014-05-30 | $6,000,472 | $6,000,472 | $0 | 1 |